A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome

NCT06544642 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

116

Enrollment

INDUSTRY

Sponsor class

Stopped Company's strategic decision

Conditions

Healthy Volunteers
Sjögren's Syndrome

Interventions

DRUG: ASP5502
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.